Clinical Correlation of Altered Molecular Signatures in Epileptic Human Hippocampus and Amygdala.
Sayed Mostafa Modarres MousaviFatemeh AlipourFarshid NoorbakhshMaryam JafarianMasoud GhadipashaJaber GharehdaghiChristoph KellinghausErwin-Josef SpeckmannWalter StummerMaryam Khaleghi GhadiriAli GorjiPublished in: Molecular neurobiology (2023)
Widespread alterations in the expression of various genes could contribute to the pathogenesis of epilepsy. The expression levels of various genes, including major inhibitory and excitatory receptors, ion channels, cell type-specific markers, and excitatory amino acid transporters, were assessed and compared between the human epileptic hippocampus and amygdala, and findings from autopsy controls. Moreover, the potential correlation between molecular alterations in epileptic brain tissues and the clinical characteristics of patients undergoing epilepsy surgery was evaluated. Our findings revealed significant and complex changes in the expression of several key regulatory genes in both the hippocampus and amygdala of patients with intractable epilepsy. The expression changes in various genes differed considerably between the epileptic hippocampus and amygdala. Different correlation patterns were observed between changes in gene expression and clinical characteristics, depending on whether the patients were considered as a whole or were subdivided. Altered molecular signatures in different groups of epileptic patients, defined within a given category, could be viewed as diagnostic biomarkers. Distinct patterns of molecular changes that distinguish these groups from each other appear to be associated with epilepsy-specific functional consequences.
Keyphrases
- poor prognosis
- prefrontal cortex
- genome wide
- gene expression
- functional connectivity
- end stage renal disease
- resting state
- endothelial cells
- temporal lobe epilepsy
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- binding protein
- dna methylation
- cognitive impairment
- minimally invasive
- genome wide identification
- single molecule
- risk assessment
- coronary artery bypass
- multiple sclerosis
- percutaneous coronary intervention
- atrial fibrillation
- human health